Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ RCKT′s IND for RP-A701 in Dilated Cardiomyopathy Gets FDA Clearance (Zacks) +++ ROCKET PHARMACEUTICALS Aktie +3,61%

COLOPLAST Aktie

 >COLOPLAST Aktienkurs 
80.8 EUR    +0.3%    (Tradegate)
Ask: 80.82 EUR / 70 Stück
Bid: 80.8 EUR / 70 Stück
Tagesumsatz: 2147 Stück
Realtime Kurs von 8 bis 22 Uhr!
COLOPLAST Aktie über LYNX handeln
>COLOPLAST Performance
1 Woche: -2,5%
1 Monat: -6,7%
3 Monate: -18,4%
6 Monate: -24,6%
1 Jahr: -29,1%
laufendes Jahr: -24,6%
>COLOPLAST Aktie
Name:  COLOPLAST NAM. B DK 1
Land:  Dänemark
Sektor:  Gesundheit
ISIN/ Wkn:  DK0060448595 / A1KAGC
Symbol/ Ticker:  CBHD (Frankfurt)
Kürzel:  FRA:CBHD, ETR:CBHD, CBHD:GR
Index:  -
Webseite:  https://www.coloplast.com..
Marktkapitalisierung:  19250 Mio. EUR
Umsatz:  24060.4 Mio. EUR
EBITDA:  7298.64 Mio. EUR
Gewinn je Aktie:  2.346 EUR
Schulden:  21004.15 Mio. EUR
Liquide Mittel:  631.16 Mio. EUR
Umsatz-/ Gewinnwachstum:  5.2% / -27.2%
KGV/ KGV lG:  30.99 / 23.26
KUV/ KBV/ PEG:  5.07 / 8.32 / 2.45
Gewinnm./ Eigenkapitalr.:  16.35% / 27.42%
Dividende je Aktie:  2.95 EUR
Dividendenrendite/ -schätzung:  3.5% / 3.52%
Div. Historie:  08.05.25 - 0.67018€
06.12.24 - 2.27941€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  COLOPLAST
Letzte Datenerhebung:  01.07.25
>COLOPLAST Eigentümer
Aktien: 207.37 Mio. St.
f.h. Aktien: 142.58 Mio. St.
Insider Eigner: 29.8%
Instit. Eigner: 28.47%
Leerverk. Aktien: -
 >COLOPLAST Anleihen 
Es sind 2 Anleihen zur COLOPLAST Aktie bekannt.
>COLOPLAST Peer Group

 
03.06.25 - 13:00
Coloplast A/S - Invitation to Coloplast′s Capital Markets Day on 2 September 2025 (GlobeNewswire EN)
 
The event will take place on Tuesday, 2 September 2025 at Clarion Hotel (Copenhagen airport)Ellehammersvej 20, 2770 Kastrupfrom 10.30 - 17.00 CEST(Central European Summer Time)...
07.05.25 - 23:48
XETR: DIVIDEND/INTEREST INFORMATION - 08.05.2025 - DK0060448595 (XETRA)
 
Das Instrument CBHD DK0060448595 COLOPLAST NAM. B DK 1 EQUITY wird ex Dividende/Zinsen gehandelt am 08.05.2025 The instrument CBHD DK0060448595 COLOPLAST NAM. B DK 1 EQUITY has its ex-dividend/interest day on 08.05.2025...
06.05.25 - 12:31
Coloplast Seeks to Restore Investor Trust With Firing of CEO (Bloomberg)
 
Coloplast A/S fired its chief executive officer to restore investor confidence after the medical equipment maker failed to deliver sufficient shareholder returns....
06.05.25 - 11:36
Coloplast shares fall 5% after CEO exit, weaker Q2 results (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
05.05.25 - 17:15
Coloplast A/S CEO Kristian Villumsen steps down as of today (GlobeNewswire EN)
 
Coloplast CEO Kristian Villumsen steps down from his CEO position as of today. The Board of Directors has asked Lars Rasmussen to step in as interim CEO....
01.05.25 - 12:27
Coloplast A/S Revised guidance for FY 2024/25 (GlobeNewswire EN)
 
Coloplast revises financial guidance for FY 2024/25 and pre-announces H1 2024/25 key financial figures...
15.04.25 - 14:09
Coloplast A/S - H1 2024/25 Earnings Release - Invitation to conference call on 6 May 2025 at 11.00am CEST (GlobeNewswire EN)
 
Tuesday, 6 May 2025 at 11.00 - 12.00am CESTIn connection with the publication of Coloplast's interim financial results for H1 2024/25, to be released same day around 07.30am CEST, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Coloplast's website approximately 1 hour before the conference call.The webcast of the conference call will be available during and after the event....
27.03.25 - 14:00
Arjo appoints Eva Brike as new Executive Vice President Human Resources & Sustainability and member of the Arjo Management Team (Cision)
 
Arjo has appointed Eva Brike as new EVP Human Resources & Sustainability starting June 1, 2025. Eva succeeds Marion Gullstrand, who after a long operational career has chosen to pursue new opportunities. Eva Brike most recently held the position of Vice President People & Culture at Atos Medical, part of Coloplast. She has a solid background that also includes positions at Rosti Group and Resurs Bank. “We are very pleased to welcome Eva Brike to Arjo. Her experience and expertise will be an asset in the continued work to strengthen both the organization and our leadership and culture –...
14.03.25 - 11:27
Coloplast Finance B.V. - Decisions at the Annual General Meeting (GlobeNewswire EN)
 
On 14 March 2025, Coloplast Finance B.V. held its Annual General Meeting. At the Annual General Meeting, the sole shareholder, Coloplast A/S, approved the annual report for the financial year 2023/24. In addition, Ernst & Young Accountants LLP was appointed as auditor for Coloplast Finance B.V....
03.03.25 - 13:09
Coloplast upgraded to ′outperform′ as RBC sees strong upside potential (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
04.02.25 - 20:30
Coloplast targets 8%-9% organic growth for FY 2025 amid Kerecis expansion and new launches (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
04.02.25 - 19:00
Coloplast A/S GAAP EPS of DKK4.63, revenue of DKK7.03B (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
04.02.25 - 13:15
Coloplast A/S - Allocation of Share Options (GlobeNewswire EN)
 
Report on transactions of executives and related parties in Coloplast shares and related securities...
29.01.25 - 14:48
Bernstein upgrades Coloplast, Elekta; Philips still top pick (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
22.01.25 - 10:36
Coloplast A/S - Q1 2024/25 Earnings Release - Invitation to conference call on 4 February 2025 at 11.00am CET (correction) (GlobeNewswire EN)
 
Tuesday, 4 February 2025 at 11.00 - 12.00am CET (corrected from 10.00 - 11.00am CET in an earlier version of this invitation)In connection with the publication of Coloplast's interim financial results for Q1 2024/25, to be released same day around 07.30am CET, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Coloplast's website approximately 1 hour before the conference call.The webcast of the conference call will be available during and after the event. ...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Junge Gänse haben große Mäuler. - Sprichwort Deutschland
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!